API
CDMO
About us
Services

Kraeber - CDMO/CMO

Kraeber + Co GmbH is an independent family owned business, established 1980 in Ellerbek on the outskirts of Hamburg, Germany. We sell Active Pharmaceutical Ingredients (APIs) and intermediates, which are synthetically derived products or biological substances of animal or plant origin. We supply our products worldwide to the pharmaceutical, cosmetic, biotechnology, nutraceutical industry and laboratories.

Address: Waldhofstraße 14, 25474, Ellerbek
Germany
Germany Local time:

EU-GMP and DIN EN ISO 9001:2015

Pioneer in the fractionation of sheep plasma

Pure & sterile high-quality products

Our services:

Drug Substance

Production scale:

medium

Response time:

label.follow_us Follow us:
Employees:
30+
Established in:
1980

Services

Drug Substance (CDMO/CRO)

Biologics are complex medicines derived from living cells, used in treating diseases such as cancer, autoimmune disorders, and more. CDMOs specializing in biologics offer capabilities in cell line development, upstream/downstream processing, and sterile fill-finish.
Contact supplier

Replies quickly

Small molecule APIs form the backbone of many pharmaceutical drugs due to their low molecular weight and ease of synthesis. They are widely used in treating a range of diseases and are typically produced through chemical synthesis in GMP-compliant facilities.
Contact supplier

Replies quickly

Contact Kraeber & Co GmbH for Contract Services Expertise

Connect with Kraeber & Co GmbH, a leading pharmaceutical company from Germany. They offer specialized Drug Substance (CDMO/CRO). Contact Kraeber & Co GmbH for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.


Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.


Key Functions of Drug Substance CDMOs/CROs:


  • API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.

  • Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.

  • GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.

  • Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.

  • Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.


Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.

Kraeber


Kraeber + Co GmbH is an independent family owned business, established 1980 in Ellerbek on the outskirts of Hamburg, Germany. We sell Active Pharmaceutical Ingredients (APIs) and intermediates, which are synthetically derived products or biological substances of animal or plant origin. We supply our products worldwide to the pharmaceutical, cosmetic, biotechnology, nutraceutical industry and laboratories.